Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117087) titled 'Study on the efficacy and safety of Nalbuphine Hydrochloride Injection for sedation/Anesthesia in Elderly patients undergoing digestive endoscopy diagnosis and treatment' on Jan. 20.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Suizhou Central Hospital
Condition:
None
Intervention:
Nalbuphine <=0.05mg/kg:N/A
0.05 < nalbuphine <=0.075mg/kg:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-20
Target Sample Size: Nalbuphine <=0.05mg/kg:166;0.05 < nalbuphine <=0.075mg/kg:166;0.075 < nalbuphine <=0.1mg/kg:166;
Countries of Recruitment:
China...